|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
|
|---|---|---|
| Revenue | ||
| Cost of revenue | ||
| Gross profit | ||
| Operating expenses: | ||
| Research and development | ||
| Selling, general and administrative expenses | ||
| Total operating expenses | ||
| Loss from operations | ||
| Other expenses, net | ||
| Interest expenses | ||
| Loss before income taxes | ||
| Net loss | ||
| Net loss per share attributable to shareholders, basic | ||
| Net loss per share attributable to shareholders, diluted | ||
| Weighted-average shares outstanding used to compute net loss per share, basic | ||
| Weighted-average shares outstanding used to compute net loss per share, diluted |
Loading...
